Assignment 4 Brilliant Answers ONLY
| Points: 300 | Assignment 4: Legal and Ethical Considerations in Marketing, Product Safety, and Intellectual Property | |||
| Criteria | Unacceptable Below 70% F | Fair 70-79% C | Proficient 80-89% B | Exemplary 90-100% A |
| 1. Research three to five (3-5) ethical issues relating to marketing and advertising, intellectual property, and regulation of product safety and examine whether PharmaCARE violated any of the issues in question. Weight: 15% | Did not submit or incompletely researched three to five (3-5) ethical issues relating to marketing and advertising, intellectual property, and regulation of product safety and examine whether PharmaCARE violated any of the issues in question.. | Partially researched three to five (3-5) ethical issues relating to marketing and advertising, intellectual property, and regulation of product safety and examine whether PharmaCARE violated any of the issues in question. | Satisfactorily researched three to five (3-5) ethical issues relating to marketing and advertising, intellectual property, and regulation of product safety and examine whether PharmaCARE violated any of the issues in question. | Thoroughly researched three to five (3-5) ethical issues relating to marketing and advertising, intellectual property, and regulation of product safety and examine whether PharmaCARE violated any of the issues in question. |
| 2. Argue for or against Direct-to-Consumer (DTC) marketing by drug companies. | Did not submit or incompletely argued for or against Direct-to-Consumer (DTC) marketing by drug companies. | Partially argued for or against Direct-to-Consumer (DTC) marketing by drug companies. | Satisfactorily argued for or against Direct-to-Consumer (DTC) marketing by drug companies. | Thoroughly argued for or against Direct-to-Consumer (DTC) marketing by drug companies. |
| 3. Determine the parties responsible for regulating compounding pharmacies under the current regulatory scheme, the actions that either these parties or the Food and Drug Administration (FDA) could / should have taken in this scenario, and whether PharmaCARE could face legal exposure surrounding its practices. Support your response. Weight: 15% | Did not submit or incompletely determined the parties responsible for regulating compounding pharmacies under the current regulatory scheme, the actions that either these parties or the Food and Drug Administration (FDA) could / should have taken in this scenario, and whether PharmaCARE could face legal exposure surrounding its practices. Did not submit or incompletely supported your response. | Partially determined the parties responsible for regulating compounding pharmacies under the current regulatory scheme, the actions that either these parties or the Food and Drug Administration (FDA) could / should have taken in this scenario, and whether PharmaCARE could face legal exposure surrounding its practices. Partially supported your response. | Satisfactorily determined the parties responsible for regulating compounding pharmacies under the current regulatory scheme, the actions that either these parties or the Food and Drug Administration (FDA) could / should have taken in this scenario, and whether PharmaCARE could face legal exposure surrounding its practices. Satisfactorily supported your response. | Thoroughly determined the parties responsible for regulating compounding pharmacies under the current regulatory scheme, the actions that either these parties or the Food and Drug Administration (FDA) could / should have taken in this scenario, and whether PharmaCARE could face legal exposure surrounding its practices. Thoroughly supported your response. |
| 4. Analyze the manner in which PharmaCARE used U.S. law to protect its own intellectual property and if John has any claim to being the true “inventor” of AD23. Suggest at least three (3) ways the company could compensate John for the use of his intellectual property. Weight: 15% | Did not submit or incompletely analyzed the manner in which PharmaCARE used U.S. law to protect its own intellectual property and if John has any claim to being the true “inventor” of AD23. Did not submit or incompletely suggested at least three (3) ways the company could compensate John for the use of his intellectual property. | Partially analyzed the manner in which PharmaCARE used U.S. law to protect its own intellectual property and if John has any claim to being the true “inventor” of AD23. Partially suggested at least three (3) ways the company could compensate John for the use of his intellectual property. | Satisfactorily analyzed the manner in which PharmaCARE used U.S. law to protect its own intellectual property and if John has any claim to being the true “inventor” of AD23. Satisfactorily suggested at least three (3) ways the company could compensate John for the use of his intellectual property. | Thoroughlyanalyzed the manner in which PharmaCARE used U.S. law to protect its own intellectual property and if John has any claim to being the true “inventor” of AD23. Thoroughly suggested at least three (3) ways the company could compensate John for the use of his intellectual property. |
| 5. Summarize at least one (1) current example (within the past two [2] years) of intellectual property theft, and examine the effect on that company’s brand. Weight: 10% | Did not submit or incompletely summarized at least one (1) current example (within the past two [2] years) of intellectual property theft, and examine the effect on that company’s brand. | Partially summarized at least one (1) current example (within the past two [2] years) of intellectual property theft, and examine the effect on that company’s brand. | Satisfactorily summarized at least one (1) current example (within the past two [2] years) of intellectual property theft, and examine the effect on that company’s brand. | Thoroughlysummarized at least one (1) current example (within the past two [2] years) of intellectual property theft, and examine the effect on that company’s brand. |
| 6. Analyze the potential issue surrounding the death of John’s wife and other potential litigants against PharmaCARE as a result of AD23. Weight: 10% | Did not submit or incompletely analyzed the potential issue surrounding the death of John’s wife and other potential litigants against PharmaCARE as a result of AD23. | Partially analyzed the potential issue surrounding the death of John’s wife and other potential litigants against PharmaCARE as a result of AD23. | Satisfactorily analyzed the potential issue surrounding the death of John’s wife and other potential litigants against PharmaCARE as a result of AD23. | Thoroughlyanalyzed the potential issue surrounding the death of John’s wife and other potential litigants against PharmaCARE as a result of AD23. |
| 7. Specify both the major arguments that John can make to claim that he is a whistleblower and the type of protections that he should be afforded. Justify your response. | Did not submit or incompletely specified both the major arguments that John can make to claim that he is a whistleblower and the type of protections that he should be afforded. Did not submit or incompletely justified your response. | Partially specified both the major arguments that John can make to claim that he is a whistleblower and the type of protections that he should be afforded. Partially justified your response. | Satisfactorily specified both the major arguments that John can make to claim that he is a whistleblower and the type of protections that he should be afforded. Satisfactorily justified your response. | Thoroughly specified both the major arguments that John can make to claim that he is a whistleblower and the type of protections that he should be afforded. Thoroughly justified your response. |
| 8. 3 references Weight: 5% | No references provided | Does not meet the required number of references; some or all references poor quality choices. | Meets number of required references; all references high quality choices. | Exceeds number of required references; all references high quality choices. |
| 9. Clarity, writing mechanics, and formatting requirements Weight: 10% | More than 6 errors present | 5-6 errors present | 3-4 errors present | 0-2 errors present |
